Nicole Keeter, PA
Physician Assistant · Fort Mill, SCNPI 1396997110
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $89,012 of the $129,367 with a category attached, or 68.8%. Johnson & Johnson accounts for 81.2% of it on its own, with 33 other manufacturers making up the rest. Among physician assistant clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 865 payments — averaging $149.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$105K
- Janssen Scientific Affairs, LLC$7K
- UCB, Inc.$2K
- E.r. Squibb & Sons, L.L.C.$2K
- Novartis$2K
- AbbVie$2K
- plus $8K from 28 others
What the payments were for
- Consulting fees$3,0322%
- Speaking & faculty fees$89,01269%
- Travel & lodging$17,51014%
- Food & beverage$19,16915%
- Education$6430%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 169 | $105,061 |
| Janssen Scientific Affairs, LLC | 19 | $7,107 |
| UCB, Inc. | 35 | $2,300 |
| E.r. Squibb & Sons, L.L.C. | 70 | $2,207 |
| Novartis | 33 | $2,176 |
| AbbVie | 139 | $2,109 |
| Sanofi | 39 | $1,128 |
| Sun Pharmaceutical Industries Inc. | 46 | $1,063 |
| Lilly USA, LLC | 32 | $893 |
| Arcutis Biotherapeutics, Inc. | 31 | $774 |
| Dermavant Sciences, Inc. | 63 | $697 |
| Amgen | 31 | $648 |
| Pfizer | 35 | $561 |
| Galderma Laboratories, L.p. | 25 | $460 |
| Regeneron Healthcare Solutions, Inc. | 32 | $459 |
| Organon | 11 | $410 |
| Incyte Corporation | 15 | $349 |
| Medimetriks Pharmaceuticals, Inc. | 6 | $149 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 5 | $99 |
| EPI Health, LLC | 2 | $99 |
| Regeneron | 1 | $91 |
| Mayne Pharma Commercial LLC | 5 | $72 |
| LEO Pharma Inc. | 3 | $68 |
| Boehringer Ingelheim | 3 | $62 |
| Fresenius Kabi USA, LLC | 2 | $51 |
| Journey Medical Corporation | 2 | $50 |
| Verrica Pharmaceuticals Inc. | 2 | $45 |
| Biofrontera Inc. | 2 | $39 |
| VYNE Pharmaceuticals Inc. | 2 | $37 |
| Cipher Pharmaceuticals US LLC | 1 | $25 |
| Botanix SB Inc | 1 | $23 |
| Tempus AI, Inc | 1 | $21 |
| Sandoz | 1 | $16 |
| Almirall LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$129,367 in reported general payments places this provider in the 95th percentile of 1,852 physician assistant providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OtezlaApremilast | 28 | $174,726 |
| Taltz AutoinjectorIxekizumab | 25 | $158,974 |
| TremfyaGuselkumab | 11 | $139,211 |
| Doxycycline Hyclate | 93 | $3,477 |
| Clobetasol Propionate | 61 | $2,509 |
| Fluorouracil | 44 | $2,431 |
| Metronidazole | 44 | $1,828 |
| Fluocinonide | 37 | $1,544 |
| Triamcinolone Acetonide | 100 | $1,132 |
| Ketoconazole | 111 | $1,096 |
| Nystatin | 26 | $295 |
| Mupirocin | 27 | $169 |
| Minocycline Hcl | 14 | $154 |
| Hydrocortisone | 38 | $117 |
| Dexamethasone | 11 | $66 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AmgenOtezla | $648 | $174,72628 claims |
| Johnson & JohnsonTremfya | $105,061 | $139,21111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,852 physician assistant providers in South Carolina.
Other physician assistant in Fort Mill
- Benjamin AddyWest Columbia$377K
- Michael OvercashCharleston$210K
- Allison LesterMt Pleasant$163K
- William YoungGreenville$117K
- Stephanie DavisAnderson$78K
- Vicki RobertsWest Columbia$77K
- Eric ShoupColumbia$74K
- Lauren OlsonNorth Charleston$62K
- Martha GreenSummerville$48K
- Jessica GriffithsGreenville$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.